Treatment of high-turnover bone diseases such as osteoporosis (particularly postmenopausal osteoporosis with more pronounced effects on axial bones than appendicular bones), Paget's disease of bone, Sudeck's atrophy (reflex sympathetic dystrophy), and malignant osteolysis; inhibition of osteoclast activity and stimulation of osteoblast formation and activity; reduction of bone resorption and calcium loss; management of hypercalcemia (immediate treatment); analgesic effects in certain painful bone disorders through inhibition of pain mediator release, receptor blockade, and increased β-endorphin release; suppression of gastric and pancreatic secretions without affecting gastrointestinal motility.